{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifzkc6mbunnwqtdfmzmd2i4u2ruyjl2xeq46n2dmeqxd4jcb5fg44",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhu32lew7hu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiefvhxjzucapgujroi6ekx6ifex5p6gs2ft3pw4cyn5jh3fczqal4"
    },
    "mimeType": "image/jpeg",
    "size": 1398899
  },
  "path": "/news/2026-03-cancer-drug-resistant-herpes.html",
  "publishedAt": "2026-03-24T22:20:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.",
  "title": "Cancer drug can treat drug-resistant herpes, too"
}